Lina Hemmeda,Angad Tiwari,Barakat Olajumoke Kolawole,Fathima Shehnaz Ayoobkhan,Kainat Fatima,Moshi Moshi Shabani,Mrinmoy Kundu,NagaSpurthy Reddy Anugu,Riya Mary Richard,Danya Ibrahim,Khabab Abbasher Hussien Mohamed Ahmed

Abstract:The situation in Sudan have deteriorated since the ongoing war outbreak in April 2023. This article sheds light on the pharmacological status in Sudan in terms of shortage of supply, rising demands, and regulatory issues. The ongoing civil war has acutely impacted the dilapidated pharmaceutical status of Sudan, patients have suffered from the paucity of medical services forcing an out-of-control rise in underreported morbidity and mortality. To mitigate this uprising issue, an increase in stakeholder communication is crucial to deal with this national threat and establish a system for reporting the shortage.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the current drug shortage crisis in Sudan, especially after the civil war that broke out in 2023, which has had a serious impact on public health. The paper explores in detail the reasons for the drug shortage, including supply - chain problems, increased demand, and ineffective supervision, etc., and analyzes how these factors interact against the backdrop of economic difficulties, political unrest, and intensified conflicts, leading to a severe shortage of drug supplies. In addition, the paper also puts forward a series of suggestions to alleviate the drug shortage, aiming to improve the drug supply situation in Sudan and ensure that patients can receive necessary medical treatment in a timely manner through measures such as strengthening domestic and foreign cooperation, establishing an effective drug reporting and tracking system, improving drug production quality, and controlling prices.

The critical pharmaceutical situation in Sudan 2023: A humanitarian catastrophe of civil war